glp-1 origin Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism History of glucagon-like peptide-1 receptor

Risperidone When administered concomitantly with topiramate at escalating doses of 100, 250, and 400 mg/day, there was a reduction in risperidone systemic exposure (16% and 33% for steady-state AUC at the 250 and 400 mg/day doses of topiramate)

doi: 10.1038/s41419-020-03118-0 59

Constituents Acetyl-L-Carnitine HCl Vegetarian capsule (hypromellose, water) Microcrystalline cellulose Ascorbyl palmitate Silica Free from gluten, dairy, soy, artificial preservatives, flavors, and colors

Gene set enrichment analysis (GSEA) confirmed the association between GSH metabolism and MTX resistance

Bydureon contains a lower dosage of Exenatide (2mcg per dose), particularly because of its slow-release mechanism

One paper suggested that GLP-1s may improve some gut health symptoms (such as abdominal pain) but worsen others (such as regularity and constipation)